Skip to main content
Article thumbnail
Location of Repository

Clinical and cost-effectiveness of internal limiting membrane peeling for patients with idiopathic full thickness macular hole. Protocol for a Randomised Controlled Trial : FILMS (Full-thickness macular hole and Internal Limiting Membrane peeling Study)

By Noemi Lois, Jennifer Margaret Burr, John David Norrie, Luke David Vale, Jonathan Alistair Cook, Alison Mary McDonald and FILMS Group

Abstract

Background: A full-thickness macular hole (FTMH) is a common retinal condition associated with impaired vision. Randomised controlled trials (RCTs) have demonstrated that surgery, by means of pars plana vitrectomy and post-operative intraocular tamponade with gas, is effective for stage 2, 3 and 4 FTMH. Internal limiting membrane (ILM) peeling has been introduced as an additional surgical manoeuvre to increase the success of the surgery; i.e. increase rates of hole closure and visual improvement. However, little robust evidence exists supporting the superiority of ILM peeling compared with no-peeling techniques. The purpose of FILMS (Fullthickness macular hole and Internal Limiting Membrane peeling Study) is to determine whether ILM peeling improves the visual function, the anatomical closure of FTMH, and the quality of life of patients affected by this disorder, and the cost-effectiveness of the surgery.\ud Methods/Design: Patients with stage 2–3 idiopathic FTMH of less or equal than 18 months duration (based on symptoms reported by the participant) and with a visual acuity ≤ 20/40 in the study eye will be enrolled in this FILMS from eight sites across the UK and Ireland. Participants will be randomised to receive combined cataract surgery (phacoemulsification and intraocular lens implantation) and pars plana vitrectomy with postoperative intraocular tamponade with gas, with or without ILM peeling. The primary outcome is distance visual acuity at 6 months. Secondary outcomes include distance visual acuity at 3 and 24 months, near visual acuity at 3, 6, and 24 months, contrast sensitivity at 6 months, reading speed at 6 months, anatomical closure of the macular hole at each time point (1, 3, 6, and 24 months), health related quality of life (HRQOL) at six months, costs to the health service and the participant, incremental costs per quality adjusted life year (QALY) and adverse events.\ud Discussion: FILMS will provide high quality evidence on the role of ILM peeling in FTMH surgery.\ud Trial registration: This trial is registered with Current Controlled Trials ISRCTN number 33175422 and Clinical Trials.gov identifier NCT00286507.Chief Scientist Office, Scotland (project ref no CZH/4/235), NHS GrampianPeer reviewedPublisher PD

Topics: Macular Degeneration, Randomised Controlled Trial, Surgery, RE Ophthalmology
Publisher: BMC
Year: 2008
DOI identifier: 10.1186/1745-6215-9-61
OAI identifier: oai:aura.abdn.ac.uk:2164/269
Journal:

Suggested articles

Citations

  1. (2001). Age-Related Eye Disease Study Research Group: The age-related eye disease study (AREDS) system for classifying cataracts from photographs:
  2. (2002). et al.: Contribution of intravitreal infracyanine green to macular hole and epimacular membrane surgery: preliminary study.
  3. (2001). Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci
  4. (1997). for the Vitrectomy for Treatment of Macular Hole Study Group: Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Arch Ophthalmol
  5. (1988). Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol
  6. (1996). IL: Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group.
  7. (1970). JD: Macular holes.
  8. (2001). Kampik A: Macular changes after peeling of the internal limiting membrane in macular hole surgery.
  9. (2003). Kampik A: Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci doi
  10. (2008). Lois N: Internal limiting membrane peeling in vitreo-retinal surgery. Internal limiting membrane peeling in vitreo-retinal surgery. Survey of Ophthalmol doi
  11. (2002). Macular holes: classification, epidemiology, batural history and treatment. Acta Ophthalmol Scand
  12. (2002). Macular holes: classification, epidemiology, natural history and treatment. Acta Ophthalmol Scand
  13. (1974). Minimization: A new method of assigning patients to treatment and control groups. Clin Pharmacol Ther
  14. (1999). Ophthalmol
  15. (1994). S: Vitrectomy for prevention of macular holes. Results of a randomised multicenter clinical trial. Ophthalmology
  16. (2001). Surgical management of macular holes: a report by the American Academy of Ophthalmology. Ophthalmology
  17. (2003). Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery. doi
  18. (1997). Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol
  19. (1987). Wong D: Trends in vitreoretinal surgery at a tertiary referral centre:
  20. (2005). Wong VW: Idiopathic macular hole surgery in Chinese patients: a randomised study to cpmpare indocyanine green-assisted internal limiting membrane peeling with no internal limiting membrane peeling. Hong Kong Med J

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.